feed,title,long_url,short_url
Benzinga,"Autoimmune Biotech Scores $26M Payment, Up To $139M To Advance Phase 3 Research",https://benzinga.com/general/biotech/22/12/29975999/autoimmune-biotech-scores-26m-payment-up-to-139m-to-advance-phase-3-research,https://bit.ly/3HdxC9S
Benzinga,"Perfect Stock Jumps 10% - Analyst Calls PERF An Ideal Blend Of Social Commerce, Augmented Reality",https://benzinga.com/news/22/12/29976199/perfect-stock-jumps-10-analyst-calls-perf-an-ideal-blend-of-social-commerce-augmented-reality,https://bit.ly/3HbH3GZ
